Literature DB >> 22308501

Go2 G protein mediates galanin inhibitory effects on insulin release from pancreatic β cells.

Guanghua Tang1, Ying Wang, Sangeun Park, Neil S Bajpayee, Diana Vi, Yoshiko Nagaoka, Lutz Birnbaumer, Meisheng Jiang.   

Abstract

The neuropeptide galanin regulates numerous physiological activities in the body, including feeding and metabolism, learning and memory, nociception and spinal reflexes, and anxiety and related behaviors. Modulation of blood glucose levels by suppressing insulin release was the first reported activity for galanin. This inhibition was mediated by one or more pertussis toxin-sensitive G proteins of the G(i/o) subfamily. However, the molecular identities of the specific G protein(s) and intracellular effectors have not been fully revealed. Recently, we demonstrated that mice lacking G(o)2, but not other members of the G(i/o) protein family, secrete more insulin than controls upon glucose challenge, indicating that G(o)2 is a major transducer for the inhibitory regulation of insulin secretion. In this study, we investigated galanin signaling mechanisms in β cells using cell biological and electrophysiological approaches. We found that islets lacking G(o)2, but not other G(i/o) proteins, lose the inhibitory effect of galanin on insulin release. Potentiation of ATP-sensitive potassium (K(ATP)) and inhibition of calcium currents by galanin were disrupted by anti-G(o)2α antibodies. Galanin actions on K(ATP) and calcium currents were completely lost in G(o)2(-/-) β cells. Furthermore, the hyperglycemic effect of galanin is also blunted in G(o)2(-/-) mice. Our results demonstrate that G(o)2 mediates the inhibition of insulin release by galanin by regulating both K(ATP) and Ca(2+) channels in mice. Our findings provide insight into galanin's action in glucose homeostasis. The results may also be relevant to the understanding of galanin signaling in other biological systems, especially the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22308501      PMCID: PMC3289306          DOI: 10.1073/pnas.1200100109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes.

Authors:  S Wang; C He; T Hashemi; M Bayne
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

2.  Molecular cloning and pharmacological characterization of a new galanin receptor subtype.

Authors:  S Wang; T Hashemi; C He; C Strader; M Bayne
Journal:  Mol Pharmacol       Date:  1997-09       Impact factor: 4.436

3.  Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.

Authors:  K E Smith; C Forray; M W Walker; K A Jones; J A Tamm; J Bard; T A Branchek; D L Linemeyer; C Gerald
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

Review 4.  Toward understanding the assembly and structure of KATP channels.

Authors:  L Aguilar-Bryan; J P Clement; G Gonzalez; K Kunjilwar; A Babenko; J Bryan
Journal:  Physiol Rev       Date:  1998-01       Impact factor: 37.312

5.  Modulation of reconstituted ATP-sensitive K(+)-channels by GTP-binding proteins in a mammalian cell line.

Authors:  J A Sánchez; T Gonoi; N Inagaki; T Katada; S Seino
Journal:  J Physiol       Date:  1998-03-01       Impact factor: 5.182

6.  Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2.

Authors:  M T Guillam; E Hümmler; E Schaerer; J I Yeh; M J Birnbaum; F Beermann; A Schmidt; N Dériaz; B Thorens; J Y Wu
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

7.  Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells.

Authors:  E M Parker; D G Izzarelli; H P Nowak; C D Mahle; L G Iben; J Wang; M E Goldstein
Journal:  Brain Res Mol Brain Res       Date:  1995-12-28

8.  Multiple neurological abnormalities in mice deficient in the G protein Go.

Authors:  M Jiang; M S Gold; G Boulay; K Spicher; M Peyton; P Brabet; Y Srinivasan; U Rudolph; G Ellison; L Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

9.  Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor.

Authors:  Z Fathi; P M Battaglino; L G Iben; H Li; E Baker; D Zhang; R McGovern; C D Mahle; G R Sutherland; T P Iismaa; K E Dickinson; I A Zimanyi
Journal:  Brain Res Mol Brain Res       Date:  1998-07-15

Review 10.  Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm.

Authors:  F M Matschinsky
Journal:  Diabetes       Date:  1996-02       Impact factor: 9.461

View more
  16 in total

1.  Low levels of plasma galanin in obese subjects with hypertension.

Authors:  P Fang; M Yu; X Gu; M Shi; Y Zhu; Z Zhang; P Bo
Journal:  J Endocrinol Invest       Date:  2016-08-18       Impact factor: 4.256

2.  Novel Targets for Developing Antiseizure and, Potentially, Antiepileptogenic Drugs.

Authors:  Dipan C Patel; Karen S Wilcox; Cameron S Metcalf
Journal:  Epilepsy Curr       Date:  2017 Sep-Oct       Impact factor: 7.500

3.  Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055.

Authors:  Sean P Flynn; H Steve White
Journal:  Neuropeptides       Date:  2015-01-21       Impact factor: 3.286

4.  Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

Authors:  Cameron S Metcalf; Misty D Smith; Brian D Klein; Daniel R McDougle; Liuyin Zhang; Grzegorz Bulaj
Journal:  Neurochem Res       Date:  2017-04-06       Impact factor: 3.996

Review 5.  Modulation of pancreatic exocrine and endocrine secretion.

Authors:  Rashmi Chandra; Rodger A Liddle
Journal:  Curr Opin Gastroenterol       Date:  2013-09       Impact factor: 3.287

Review 6.  Inter-organ communication and regulation of beta cell function.

Authors:  Mehboob A Hussain; Elina Akalestou; Woo-Jin Song
Journal:  Diabetologia       Date:  2016-01-20       Impact factor: 10.122

Review 7.  There is Kisspeptin - And Then There is Kisspeptin.

Authors:  Mehboob A Hussain; Woo-Jin Song; Andrew Wolfe
Journal:  Trends Endocrinol Metab       Date:  2015-10       Impact factor: 12.015

8.  Insulin secretion stimulated by L-arginine and its metabolite L-ornithine depends on Gα(i2).

Authors:  Veronika Leiss; Katarina Flockerzie; Ana Novakovic; Michaela Rath; Annika Schönsiegel; Lutz Birnbaumer; Annette Schürmann; Christian Harteneck; Bernd Nürnberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-09       Impact factor: 4.310

9.  Glucagon regulates hepatic kisspeptin to impair insulin secretion.

Authors:  Woo-Jin Song; Prosenjit Mondal; Andrew Wolfe; Laura C Alonso; Rachel Stamateris; Benny W T Ong; Owen C Lim; Kil S Yang; Sally Radovick; Horacio J Novaira; Emily A Farber; Charles R Farber; Stephen D Turner; Mehboob A Hussain
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

10.  Suppression of insulin production and secretion by a decretin hormone.

Authors:  Ronald W Alfa; Sangbin Park; Kathleen-Rose Skelly; Gregory Poffenberger; Nimit Jain; Xueying Gu; Lutz Kockel; Jing Wang; Yinghua Liu; Alvin C Powers; Seung K Kim
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.